🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Blood Flow Restriction Training in Acute Geriatric Rehabilitation

RecruitingNAAges 65 Years - anyAllUniversity Hospital, Bonn
NCT07291765 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: Older adults have a reduced ability to build and maintain muscle mass due to age-related changes in the muscular system. The resulting sarcopenia can lead to a number of health problems and limitations, such as an increased risk of falling and reduced mobility, which can affect quality of life and increase the risk of disease. To increase muscle mass and strength, high-intensity resistance training with loads of 70 to 85% of the repetition maximum (1RM) is recommended. However, this type of training poses a major challenge in the rehabilitation sector, as there is also an increased risk of injury due to physical limitations in old age. According to current research, low-intensity occlusion training could therefore represent a safe and effective training alternative. The aim of this study is therefore to examine the feasibility and effects of blood flow restriction training (B

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults \>65 years with a two week hospitalized acute rehabilitation after a fracture closed to the hip joint Exclusion Criteria: * Sickle Cell Anemia * Iatrogenic changes of the vessels at the place of the tournqiuet application (e.g. Stents)
💊

What it tests

  • Stationary Bike + Blood-Flow-Restriction
  • Stationary Bike + Sham-Blood-Flow-Restriction
  • Acute geriatric rehabilitation + No additional Intervention
📍

Where

1 site
St. Marien-Hospital Köln
Cologne, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy